198 related articles for article (PubMed ID: 26872079)
1. Severe potential drug-drug interactions in older adults with dementia and associated factors.
Bogetti-Salazar M; González-González C; Juárez-Cedillo T; Sánchez-García S; Rosas-Carrasco O
Clinics (Sao Paulo); 2016 Jan; 71(1):17-21. PubMed ID: 26872079
[TBL] [Abstract][Full Text] [Related]
2. Potentially inappropriate medications and drug-drug interactions in home-dwelling people with mild dementia.
Oesterhus R; Aarsland D; Soennesyn H; Rongve A; Selbaek G; Kjosavik SR
Int J Geriatr Psychiatry; 2017 Feb; 32(2):183-192. PubMed ID: 26924491
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
Loya AM; González-Stuart A; Rivera JO
Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia.
Zhu L; Rochon PA; Gruneir A; Wu W; Giannakeas V; Austin PC; Stall NM; McCarthy L; Alberga A; Herrmann N; Gill SS; Bronskill SE
Drugs Aging; 2019 Sep; 36(9):875-884. PubMed ID: 31309528
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data.
Clague F; Mercer SW; McLean G; Reynish E; Guthrie B
Age Ageing; 2017 Jan; 46(1):33-39. PubMed ID: 28181629
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US.
Maust DT; Strominger J; Kim HM; Langa KM; Bynum JPW; Chang CH; Kales HC; Zivin K; Solway E; Marcus SC
JAMA; 2021 Mar; 325(10):952-961. PubMed ID: 33687462
[TBL] [Abstract][Full Text] [Related]
7. The Longitudinal Association Between a Discrepancy Measure of Anosognosia in Patients with Dementia, Caregiver Burden and Depression.
Perales J; Turró-Garriga O; Gascón-Bayarri J; Reñé-Ramírez R; Conde-Sala JL
J Alzheimers Dis; 2016 May; 53(3):1133-43. PubMed ID: 27258415
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.
Holtzman C; Armon C; Tedaldi E; Chmiel JS; Buchacz K; Wood K; Brooks JT;
J Gen Intern Med; 2013 Oct; 28(10):1302-10. PubMed ID: 23605401
[TBL] [Abstract][Full Text] [Related]
9. Concomitant use of drugs known to cause interactions with oral antiplatelets-polypharmacy in acute coronary syndrome outpatients in Finland.
Prami T; Khanfir H; Hasvold P; Reissell E; Airaksinen J; Kytö V
Eur J Clin Pharmacol; 2020 Feb; 76(2):257-265. PubMed ID: 31773191
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.
Nørgaard A; Jensen-Dahm C; Gasse C; Hansen ES; Waldemar G
J Alzheimers Dis; 2017; 56(2):707-716. PubMed ID: 28035931
[TBL] [Abstract][Full Text] [Related]
12. Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing.
Walsh KA; O'Regan NA; Byrne S; Browne J; Meagher DJ; Timmons S
Int Psychogeriatr; 2016 Nov; 28(11):1807-1820. PubMed ID: 27527842
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey.
Montgomery W; Goren A; Kahle-Wrobleski K; Nakamura T; Ueda K
BMC Geriatr; 2018 Jun; 18(1):141. PubMed ID: 29898679
[TBL] [Abstract][Full Text] [Related]
14. Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.
Hoffmann F; van den Bussche H; Wiese B; Schön G; Koller D; Eisele M; Glaeske G; Scherer M; Kaduszkiewicz H
BMC Psychiatry; 2011 Dec; 11():190. PubMed ID: 22145796
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study.
Kristensen RU; Nørgaard A; Jensen-Dahm C; Gasse C; Wimberley T; Waldemar G
J Alzheimers Dis; 2018; 63(1):383-394. PubMed ID: 29578483
[TBL] [Abstract][Full Text] [Related]
16. [Neuropsychiatric symptoms in older adults with dementia and their relationship to disease severity].
Acosta-Castillo GI; Luisa Sosa A; Orozco R; Borges G
Rev Invest Clin; 2012; 64(4):354-63. PubMed ID: 23227586
[TBL] [Abstract][Full Text] [Related]
17. Exploring the prevalence of and factors associated with pain: a cross-sectional study of community-dwelling people with dementia.
Barry HE; Parsons C; Passmore AP; Hughes CM
Health Soc Care Community; 2016 May; 24(3):270-82. PubMed ID: 25708056
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
